Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg

Published:2011-12-15 Issue:3 Volume:67 Page:671-674
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Okoli C.,Siccardi M.,Thomas-William S.,Dufty N.,Khonyongwa K.,Ainsworth J.,Watson J.,Cook R.,Gandhi K.,Hickinbottom G.,Owen A.,Taylor S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/67/3/671/2376397/dkr493.pdf

Reference5 articles.

1. Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

2. Determinants of Virological Response to Antiretroviral Therapy: Implications for Long-Term Strategies

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV;Expert Opinion on Drug Metabolism & Toxicology;2021-04-29

2. Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey;PLOS ONE;2019-11-21

3. CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study;Journal of NeuroVirology;2017-12-26

4. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial;PLOS ONE;2017-11-21

5. Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice;AIDS Research and Human Retroviruses;2017-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3